- Home
- INM vs DCOMP Comparison
INM vs DCOMP Comparison
Compare INM & DCOMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- DCOMP
- Stock Information
- Founded
- INM 1981
- DCOMP N/A
- Country
- INM Canada
- DCOMP United States
- Employees
- INM 13
- DCOMP 887
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- DCOMP Major Banks
- Sector
- INM Health Care
- DCOMP Finance
- Exchange
- INM Nasdaq
- DCOMP Nasdaq
- Market Cap
- INM 5.0M
- DCOMP N/A
- IPO Year
- INM N/A
- DCOMP N/A
- Fundamental
- Price
- INM $2.10
- DCOMP $18.95
- Analyst Decision
- INM
- DCOMP
- Analyst Count
- INM 0
- DCOMP 0
- Target Price
- INM N/A
- DCOMP N/A
- AVG Volume (30 Days)
- INM 120.5K
- DCOMP N/A
- Earning Date
- INM 11-13-2025
- DCOMP N/A
- Dividend Yield
- INM N/A
- DCOMP N/A
- EPS Growth
- INM N/A
- DCOMP N/A
- EPS
- INM N/A
- DCOMP N/A
- Revenue
- INM $4,942,633.00
- DCOMP N/A
- Revenue This Year
- INM N/A
- DCOMP N/A
- Revenue Next Year
- INM N/A
- DCOMP N/A
- P/E Ratio
- INM N/A
- DCOMP N/A
- Revenue Growth
- INM 7.50
- DCOMP N/A
- 52 Week Low
- INM $1.72
- DCOMP N/A
- 52 Week High
- INM $8.27
- DCOMP N/A
- Technical
- Relative Strength Index (RSI)
- INM 43.02
- DCOMP 44.05
- Support Level
- INM $2.04
- DCOMP $18.85
- Resistance Level
- INM $2.26
- DCOMP $19.29
- Average True Range (ATR)
- INM 0.14
- DCOMP 0.47
- MACD
- INM -0.01
- DCOMP -0.07
- Stochastic Oscillator
- INM 13.05
- DCOMP 26.92
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About DCOMP Dime Community Bancshares Inc. Fixed-Rate Non-Cumulative Perpetual Preferred Stock Series A
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.